Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Healthcare And Biotech Investing 101: What You Need To Know.
Article By:
Rod Raynovich
Monday, May 13, 2024 4:44 AM EDT
Healthcare as a sector represents only about 12% of the S&P 500. If you want to overweight healthcare as a sector you need to add equities. Healthcare is usually a defensive sector because of demographics and government funding through Medicare.
3 Top Biotech Stocks Worth Adding To Your Portfolio In 2024
Article By:
Zacks Investment Research
Sunday, January 7, 2024 9:00 AM EDT
Given the continuous need for innovative medical treatments, the biotech industry may be a haven despite its inherent volatility and an uncertain macroeconomic environment. Here are three top biotech stocks that will likely perform well in 2024.
Thoughts For Thursday: With War Clouds As A Backdrop The Market Is Set To End The Year On A High
Article By:
David Marshall
Thursday, December 28, 2023 7:09 AM EDT
The market looks set to end 2023 on a high note, but 2024 is less certain, particularly because though, the US does not want further action in the Gulf, it seems, Iran via its proxies is gaming for just that.
Regeneron Pharmaceuticals’ Dupixent Has Multi-Billion-Dollar Potential: Polen Capital
Note it has only been approved in Japan. And only for those whom existing treatments are ineffective. So that's a MUCH smaller market. How small I don't know. But not enough to make me bite. $REGN